Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China
· Delayed Price · Currency is CNY 3.900
-0.040 (-1.02%)
May 9, 2025, 2:45 PM CST
SHE:300158 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -1,333 | -43.98 | -51.29 | 2,617 | 262.03 | Upgrade
|
| Depreciation & Amortization | 114.59 | 118.25 | 126.01 | 125.13 | 166.29 | Upgrade
|
| Other Amortization | 5.48 | 12.23 | 21.04 | 23.04 | 34.85 | Upgrade
|
| Loss (Gain) From Sale of Assets | -11.26 | 0.29 | 0.54 | -0 | 10.65 | Upgrade
|
| Asset Writedown & Restructuring Costs | 431.03 | 7.62 | 0.94 | 13.64 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Investments | -41.97 | -45.04 | -66.05 | -2,954 | -13.98 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -20.16 | -14.04 | -6.83 | 29.74 | Upgrade
|
| Other Operating Activities | 3.9 | 28.66 | -19.73 | 33.74 | 7.05 | Upgrade
|
| Change in Accounts Receivable | 115 | 97.98 | 319.57 | 303.08 | -202.15 | Upgrade
|
| Change in Inventory | 176.5 | -132.44 | -141.24 | -163.18 | -255.4 | Upgrade
|
| Change in Accounts Payable | 270.36 | -266.99 | -78.98 | 320.12 | 163.6 | Upgrade
|
| Change in Income Taxes | - | - | -4.98 | - | - | Upgrade
|
| Change in Other Net Operating Assets | 122.77 | -3.75 | -15.42 | -39 | 22.36 | Upgrade
|
| Operating Cash Flow | -149.82 | -249.17 | 81.32 | 284.45 | 221.94 | Upgrade
|
| Operating Cash Flow Growth | - | - | -71.41% | 28.16% | 19.10% | Upgrade
|
| Capital Expenditures | -298.48 | -116.21 | -145.81 | -151.66 | -183.96 | Upgrade
|
| Sale of Property, Plant & Equipment | 7.77 | - | 1.09 | - | 13.66 | Upgrade
|
| Divestitures | 0.99 | - | - | 4,961 | - | Upgrade
|
| Investment in Securities | 282.26 | 529.83 | 2,464 | -4,462 | 199.55 | Upgrade
|
| Other Investing Activities | 46.97 | 59.22 | 77.77 | 2.24 | 14.91 | Upgrade
|
| Investing Cash Flow | 39.51 | 472.84 | 2,397 | 348.85 | 44.16 | Upgrade
|
| Long-Term Debt Issued | 38.11 | 0.1 | 80 | 424.68 | 663.45 | Upgrade
|
| Total Debt Issued | 38.11 | 0.1 | 80 | 424.68 | 663.45 | Upgrade
|
| Long-Term Debt Repaid | -53.35 | -21.65 | -379.55 | -630.48 | -396.66 | Upgrade
|
| Total Debt Repaid | -53.35 | -21.65 | -379.55 | -630.48 | -396.66 | Upgrade
|
| Net Debt Issued (Repaid) | -15.24 | -21.55 | -299.55 | -205.8 | 266.79 | Upgrade
|
| Issuance of Common Stock | - | - | 718.3 | 1.64 | 121.68 | Upgrade
|
| Repurchase of Common Stock | - | -110.67 | -586.6 | - | -120.17 | Upgrade
|
| Common Dividends Paid | -0.58 | -1.22 | -2,786 | -195.09 | -78.26 | Upgrade
|
| Other Financing Activities | -78.67 | -11.13 | -24.6 | 12.8 | 15.58 | Upgrade
|
| Financing Cash Flow | -94.49 | -144.57 | -2,979 | -386.46 | 205.61 | Upgrade
|
| Net Cash Flow | -204.8 | 79.1 | -500.4 | 246.84 | 471.72 | Upgrade
|
| Free Cash Flow | -448.3 | -365.39 | -64.49 | 132.79 | 37.98 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 249.58% | -77.25% | Upgrade
|
| Free Cash Flow Margin | -15.09% | -10.08% | -1.73% | 2.61% | 0.78% | Upgrade
|
| Free Cash Flow Per Share | -0.44 | -0.36 | -0.06 | 0.13 | 0.04 | Upgrade
|
| Cash Income Tax Paid | 183.41 | 222.42 | 208.63 | 492.35 | 401.36 | Upgrade
|
| Levered Free Cash Flow | 479.03 | -389.2 | 109.14 | 525.38 | -275.7 | Upgrade
|
| Unlevered Free Cash Flow | 479.03 | -388.44 | 117.75 | 537.65 | -262.67 | Upgrade
|
| Change in Net Working Capital | -869.21 | 340.51 | -188.09 | -448.11 | 438.06 | Upgrade
|
Updated Oct 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.